IPROACTIF (Integrated PRimary Care and Occupational Therapy for Aging and Chronic Disease Treatment to preserve Independence and Functioning) for Heart Disease

N/A

Waitlist Available

Led By Mansha Mirza, PhD, OTR/L

Research Sponsored by University of Illinois at Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial tests IPROACTIF, a program where occupational therapists help older adults and people with chronic diseases stay healthy. The program includes check-ups and sessions to manage health, stay active, and improve thinking skills. It aims to see if participants perform better in daily activities and overall health compared to usual care.

Eligible Conditions

Heart Disease
Diabetes

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Executive functioning using the Dimensional Change Card Sort Test

Executive functioning using the Executive Function Performance Test

Performance of daily living tasks using the Performance Assessment of Self-care Skills

+3 more

Secondary study objectives

Health related quality of life using the PROMIS Global Health Measure (physical and mental subscales)

Participation in life activities and roles using the Late Life Functioning and Disability Index

Physical activity level

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Usual careExperimental Treatment1 Intervention

Participants in the control group will receive usual services which might include primary care and prescription medications for chronic disease management.

Group II: IPROACTIFExperimental Treatment1 Intervention

10 weekly sessions. First two sessions focus on comprehensive assessment of physical and executive functioning, assessment of home safety and accessibility, assessment of ADL/IADL competence and performance in context; information in these areas is used by the interventionist to collaboratively identify three patient-centered goals. Goal planning is followed by 10 treatment sessions. Treatment sessions focus on chronic disease education, problem solving issues related to disease management by modifying daily routines, recommendations for embedding physical activity in everyday tasks, and environmental modifications or activity adaptations to increase ADL/IADL independence.

Do I qualify?Apply below to find out